Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals

por Ahmed, Asma, Felmlee, Daniel J.
Publicado 2015

Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E

por Lefèvre, Mathieu, Felmlee, Daniel J., Parnot, Marie, Baumert, Thomas F., Schuster, Catherine
Publicado 2014

New perspectives for preventing hepatitis C virus liver graft infection

por Felmlee, Daniel J., Coilly, Audrey, Chung, Raymond T., Samuel, Didier, Baumert, Thomas F.
Publicado 2016

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

por Felmlee, Daniel J., Hafirassou, Mohamed Lamine, Lefevre, Mathieu, Baumert, Thomas F., Schuster, Catherine
Publicado 2013

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection

por Fafi-Kremer, Samira, Fauvelle, Catherine, Felmlee, Daniel J., Zeisel, Mirjam B., Lepiller, Quentin, Fofana, Isabel, Heydmann, Laura, Stoll-Keller, Françoise, Baumert, Thomas F.
Publicado 2012

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis

por Sheridan, David A., Shawa, Isaac Thom, Thomas, E. Louise, Felmlee, Daniel J., Bridge, Simon H., Neely, Dermot, Cobbold, Jeremy F., Holmes, Elaine, Bassendine, Margaret F., Taylor-Robinson, Simon D.
Publicado 2022